Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
November 18, 2018
Alteration of Circadian Rhythms in 2D2 Transgenic Mice
Huiru Xue, Xiuli Cao, Meini Zhang
Acta Neurologica Belgica
|
June 14, 2017
Effectiveness of low dose of rituximab compared with azathioprine in Chinese patients with neuromyelitis optica: an over 2-year follow-up study
Meini Zhang, Chuntao Zhang, Peng Bai, et al.
Frontiers in Immunology
|
February 2, 2023
The circadian rhythms regulated by Cx43-signaling in the pathogenesis of Neuromyelitis Optica
Huiru Xue, Minghui Wu, Yongle Wang, et al.
BMC Ophthalmology
|
October 7, 2025
Optical coherence tomography angiography in identifying aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
Jing Dong, Xiaogang Wang, Huiru Xue, et al.
Multiple Sclerosis and Related Disorders
|
October 16, 2022
Pain in neuromyelitis optic spectrum disorder
Huiru Xue, Wen Yang, Yunfei Zhao, et al.
Multiple Sclerosis and Related Disorders
|
June 2, 2021
Differential efficacy of mycophenolate mofetil in adults with relapsing myelin oligodendrocyte glycoprotein antibody-associated disorders
Meisheng Wang, Pei Zeng, Chen Du, et al.
Brain Communications
|
September 11, 2025
Quantitative analysis of aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies titres: correlation with relapses
Martina Nasello, Mark Woodhall, Huiru Xue, et al.
Frontiers in Neurology
|
November 1, 2021
Factors Influencing the Degree of Disability in Patients With Multiple Sclerosis
Huiru Xue, Zhenzhen Yang, Li Wang, et al.
Journal of Neuroimmunology
|
March 4, 2021
Low-dose rituximab treatment for new-onset generalized myasthenia gravis
Huining Li, Zhenning Huang, Dongmei Jia, et al.
Frontiers in Immunology
|
May 4, 2026
A novel recombinant anti-cluster of differentiation 20 humanized monoclonal antibody (B001) for the treatment of neuromyelitis optica spectrum disorder: a phase 1, multicenter randomized, double-blind trial
Dongmei Jia, Huabing Wang, Wei Jiang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
November 18, 2018
Alteration of Circadian Rhythms in 2D2 Transgenic Mice
Huiru Xue, Xiuli Cao, Meini Zhang
Acta Neurologica Belgica
|
June 14, 2017
Effectiveness of low dose of rituximab compared with azathioprine in Chinese patients with neuromyelitis optica: an over 2-year follow-up study
Meini Zhang, Chuntao Zhang, Peng Bai, et al.
Frontiers in Immunology
|
February 2, 2023
The circadian rhythms regulated by Cx43-signaling in the pathogenesis of Neuromyelitis Optica
Huiru Xue, Minghui Wu, Yongle Wang, et al.
BMC Ophthalmology
|
October 7, 2025
Optical coherence tomography angiography in identifying aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
Jing Dong, Xiaogang Wang, Huiru Xue, et al.
Multiple Sclerosis and Related Disorders
|
October 16, 2022
Pain in neuromyelitis optic spectrum disorder
Huiru Xue, Wen Yang, Yunfei Zhao, et al.
Multiple Sclerosis and Related Disorders
|
June 2, 2021
Differential efficacy of mycophenolate mofetil in adults with relapsing myelin oligodendrocyte glycoprotein antibody-associated disorders
Meisheng Wang, Pei Zeng, Chen Du, et al.
Brain Communications
|
September 11, 2025
Quantitative analysis of aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies titres: correlation with relapses
Martina Nasello, Mark Woodhall, Huiru Xue, et al.
Frontiers in Neurology
|
November 1, 2021
Factors Influencing the Degree of Disability in Patients With Multiple Sclerosis
Huiru Xue, Zhenzhen Yang, Li Wang, et al.
Journal of Neuroimmunology
|
March 4, 2021
Low-dose rituximab treatment for new-onset generalized myasthenia gravis
Huining Li, Zhenning Huang, Dongmei Jia, et al.
Frontiers in Immunology
|
May 4, 2026
A novel recombinant anti-cluster of differentiation 20 humanized monoclonal antibody (B001) for the treatment of neuromyelitis optica spectrum disorder: a phase 1, multicenter randomized, double-blind trial
Dongmei Jia, Huabing Wang, Wei Jiang, et al.
Page
of 2